Search research articles
Contact Us
Filters
Showing results (1-10 of 219) with videos related to
Page
of 22
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
When evaluating parameter uncertainty is not enough: the case of dasatinib and nilotinib for imatinib-resistant chronic myeloid leukemia
Shelby D Reed
European Heart Journal
|
May 8, 2014
Statistical considerations in economic evaluations: a guide for cardiologists
Shelby D Reed
European Heart Journal
|
July 20, 2012
How country-specific should a country-specific cost-effectiveness analysis be?
Shelby D Reed
Diabetes Care
|
February 20, 2026
Comment on O'Hara et al. Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment. Diabetes Care 2025;48:1517-1523
Shelby D Reed
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
A Beginner's Guide to Understanding Curative Therapies
Don Husereau, Shelby D Reed
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 22, 2020
Moving Beyond the Tip of the Iceberg to Incorporate Patients' Perspectives and Outcomes in the Medical Device Regulatory Process
Shelby D Reed, Lori McLeod
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2016
International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions
Shelby D Reed, Gabriela Lavezzari
Journal of Clinical and Translational Science
|
September 2, 2025
Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints
Shelby D Reed, Pishoy Gouda
Cancer
|
June 8, 2012
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model
Shelby D Reed, Gary H Lyman
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 29, 2009
Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer
Shelby D Reed, Kevin A Schulman
Page
of 22
Search research articles
Search
Showing results (1-10 of 219) with videos related to
Sort By:
Page
of 22
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
When evaluating parameter uncertainty is not enough: the case of dasatinib and nilotinib for imatinib-resistant chronic myeloid leukemia
Shelby D Reed
European Heart Journal
|
May 8, 2014
Statistical considerations in economic evaluations: a guide for cardiologists
Shelby D Reed
European Heart Journal
|
July 20, 2012
How country-specific should a country-specific cost-effectiveness analysis be?
Shelby D Reed
Diabetes Care
|
February 20, 2026
Comment on O'Hara et al. Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment. Diabetes Care 2025;48:1517-1523
Shelby D Reed
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
A Beginner's Guide to Understanding Curative Therapies
Don Husereau, Shelby D Reed
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 22, 2020
Moving Beyond the Tip of the Iceberg to Incorporate Patients' Perspectives and Outcomes in the Medical Device Regulatory Process
Shelby D Reed, Lori McLeod
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2016
International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions
Shelby D Reed, Gabriela Lavezzari
Journal of Clinical and Translational Science
|
September 2, 2025
Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints
Shelby D Reed, Pishoy Gouda
Cancer
|
June 8, 2012
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model
Shelby D Reed, Gary H Lyman
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 29, 2009
Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer
Shelby D Reed, Kevin A Schulman
Page
of 22